Based on 2 analysts offering 12 month price targets for Sanara Medtech Inc
Min Forecast
$44.00+26.07%
Avg Forecast
$47.00+34.67%
Max Forecast
$50.00+43.27%
Should I buy or sell SMTI stock?
Based on 2 analysts offering ratings for Sanara Medtech Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SMTI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SMTI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their SMTI stock forecasts and price targets.
Is Sanara Medtech Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SMTI) stock is to Strong Buy SMTI stock.
Out of 2 analysts, 1 (50%) are recommending SMTI as a Strong Buy, 1 (50%) are recommending SMTI as a Buy, 0 (0%) are recommending SMTI as a Hold, 0 (0%) are recommending SMTI as a Sell, and 0 (0%) are recommending SMTI as a Strong Sell.
What is SMTI's earnings growth forecast for 2025-2025?
(NASDAQ: SMTI) Sanara Medtech's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Sanara Medtech's earnings in 2025 is -$8,363,160.
In 2025, SMTI is forecast to generate -$8,478,926 in earnings, with the lowest earnings forecast at -$8,566,338 and the highest earnings forecast at -$8,391,515.
What is SMTI's revenue growth forecast for 2025-2025?
(NASDAQ: SMTI) Sanara Medtech's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Sanara Medtech's revenue in 2025 is $78,056,873.
In 2025, SMTI is forecast to generate $937,052,459 in revenue, with the lowest revenue forecast at $937,052,459 and the highest revenue forecast at $937,052,459.
What is SMTI's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: SMTI) forecast ROA is -9.58%, which is lower than the forecast US Medical Instruments & Supplies industry average of 10.22%.
What is SMTI's Price Target?
According to 2 Wall Street analysts that have issued a 1 year SMTI price target, the average SMTI price target is $47.00, with the highest SMTI stock price forecast at $50.00 and the lowest SMTI stock price forecast at $44.00.
On average, Wall Street analysts predict that Sanara Medtech's share price could reach $47.00 by Jan 23, 2026. The average Sanara Medtech stock price prediction forecasts a potential upside of 34.67% from the current SMTI share price of $34.90.
What is SMTI's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: SMTI) Sanara Medtech's current Earnings Per Share (EPS) is -$0.99. In 2025, SMTI's EPS is forecast to hit -$0.97 (min: -$0.98, max: -$0.96).
What is SMTI's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: SMTI) forecast ROE is -21.31%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.